Pancreatic Cancer, Pagina 188Daniel D. Von Hoff, Douglas Brian Evans, Ralph H. Hruban Jones & Bartlett Learning, 2005 - 832 pagine This groundbreaking volume is the instant gold standard for authoritative information on the prevention, diagnosis, and treatment of Pancreatic Cancer. This book includes 54 state of the art chapters all with full color illustrations edited and written by world authorities on the subject. It is the first comprehensive reference available on the topic.Pancreatic cancer is the fourth leading cause of cancer death in the United States and has the worst mortality rate of any cancer. It is very likely that the number of deaths from pancreatic cancer each year will surpass the number of deaths from other more common cancers, such as breast cancer. This groundbreaking new volume is dedicated to helping curb these daunting statistics by providing a knowledge base for clinicians and scientists who want to make a difference for patients both now and in the future. Edited by an eminent team consisting of a medical oncologist, a cancer surgeon and a pathologist, with contributions from over 100 world-class experts in the field, Pancreatic Cancer includes 54 state of the art chapters -- all with full color illustrations. Special "Commentaries," written by world authorities on the subject, provide expert analysis and counterpoint to selected topics. This definitive reference is the instant gold standard for authoritative information on the prevention and treatment of this deadly disease. |
Sommario
Anatomy | 1 |
Exocrine Pancreas | 13 |
Surgical Palliation of Pancreatic | 14 |
Molecular Genetic Alterations | 27 |
Molecular Signaling Pathways | 54 |
Pancreatic Development | 71 |
Mouse Models of Exocrine Pancreatic | 98 |
Prevention | 146 |
Exocrine pancreasLocally Advanced Disease | 420 |
Endoscopic Palliation of Pancreatic | 430 |
Exocrine PancreasMetastatic Disease | 447 |
Clinical Trial Design | 461 |
COMMENTARY | 476 |
Symptom | 479 |
Miquel Porta MD | 489 |
Cachexia and Anorexia | 499 |
Exocrine PancreasDiagnosis and Staging | 156 |
CTMRIPET | 165 |
EUS ERCP | 181 |
Laparoscopic Staging | 219 |
FineNeedle Aspiration Biopsy | 232 |
The Molecular Diagnosis | 251 |
Pancreaticoduodenectomy | 265 |
The Role of Total Pancreatectomy in | 287 |
Distal Pancreatectomy | 299 |
Pylorus Preservation Versus Standard | 313 |
Pancreaticoduodenectomy with en bloc | 321 |
Epidemiology | 337 |
The Principles of Chemoradiation | 359 |
Adjuvant and Neoadjuvant Therapies | 373 |
Intraoperative Electron Beam | 405 |
Exocrine pancreasEmerging Treatment | 513 |
425 | 568 |
Tumors of the Endocrine System | 586 |
Sporadic Gastrinoma | 603 |
Sporadic Insulinoma | 613 |
VIPoma | 623 |
Pancreatic Endocrine Neoplasms | 631 |
The von HippelLindau Syndrome | 655 |
Cystic Neoplasms 715 | 663 |
Solorzano MD 51 Pathological Classification of Cystic | 716 |
Management of Metastatic N Volkan Adsay MD | 737 |
Sanjay Gupta MD Eric P Tamm MD | 750 |
Pathology of Periampullary Tumors 686 Ralph H Hruban MD | 763 |
Altre edizioni - Visualizza tutto
Pancreatic Cancer, Pagina 188 Daniel D. Von Hoff,Douglas Brian Evans,Ralph H. Hruban Visualizzazione estratti - 2005 |
Parole e frasi comuni
5-fluorouracil acinar cell adenocarcinoma adjuvant advanced pancreatic cancer Ann Surg antigen assessment atic bile duct biliary biopsy BRCA2 Cancer Res celiac chemoradiation chemotherapy chronic pancreatitis Clin Oncol clinical creatic cancer detection diagnosis disease distal dose drainage ductal adenocarcinoma duodenal endoscopic ERCP evaluation exocrine factors gastric gastrointestinal gemcitabine gene genetic hepatic artery identified imaging intraoperative invasion jaundice K-ras laparoscopic lesions liver locally advanced malignant margin markers median survival metastatic mortality mucinous mutations neoplasms obstruction pancre pancreatic adenocarcinoma pancreatic cancer pancreatic carcinoma pancreatic duct pancreatic head pancreatic resection pancreaticoduodenectomy PanINs Pathol pathway patients with pancreatic percutaneous periampullary phase portal vein postoperative preoperative protein radiation radiotherapy randomized resection risk of pancreatic role serum splenic vein staging stent superior mesenteric superior mesenteric vein surgery surgical target therapy tients tion tissue total pancreatectomy toxicity treatment trial tumor unresectable venous Yeo CJ